Navigation Links
Anpath Group, Inc. Advances Relationship With the Washington Metropolitan Area Transit Authority (Metro)
Date:10/17/2008

MOORESVILLE, N.C., Oct. 17 /PRNewswire-FirstCall/ -- Anpath Group, Inc. (OTC Bulletin Board: ANPG), reported today that its wholly-owned subsidiary, EnviroSystems, Inc. (ESI) announced that the Washington Metropolitan Area Transit Authority (Metro) has purchased additional supplies of its EnviroTru(R) Disinfectant & Cleaner Deodorizer and a stock of ESS high efficiency electrostatic mobile spraying units.

The Company stated that Metro plans to intensify its "Cleaning for Health" initiative utilizing EnviroTru(R) in combination with the ESS electrostatically charged decontamination system. According to ESI, the Metro program is a two-part program and includes a seasonal flu prevention program as well as safe guarding the health of customers through regular application of EnviroTru(R) to Metro offices, stations, rail cars, buses and other vehicles. EnviroTru(R) will be used on high hand contact areas within the system such as door handles, hand rails, fare card machines, and other surfaces customers contact when passing through the transit system. ESI had previously reported the selection of EnviroTru(R) Disinfectant by the Metro and the signing of a Prime Distributor Agreement with Electrostatic Spraying Systems, Inc.

EnviroTru(R) is a multi-purpose disinfectant, sanitizer and deodorizing cleaner, effective against numerous organisms, and also meets EPA requirements for Toxicity Category IV (minimal effects noted, no precautionary or first aid statements required; no harmful dermal, ocular, inhalation or ingestion effects). EnviroTru(R) does not require protective clothing, gloves or special ventilation and has passed the AMS 1452A, AMS 1453 and Boeing D6-7127 specifications for non-corrosion and materials compatibility. ESS electrostatic sprayers disperse fine electrically charged droplets and are capable of delivering 60% of the disinfectant on the surface versus less than 15% by traditional sprayers, and the disinfectant can be delivered in ha
'/>"/>

SOURCE Anpath Group, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Anpath Group, Inc. Announces Selection of its Disinfectant by the Washington Metropolitan Area Transit Authority (Metro)
2. Anpath Group, Inc. Announces Addition of MRSA and VRE Claims for Its EnviroTru(R) Disinfectant
3. Anpath Group, Inc. Announces Approval of its Disinfectant by the State of Florida
4. Vical Reports Second Quarter 2007 Financial Results, Allowance of Pandemic Influenza IND and Other Advances in Product Development Programs
5. Pre-clinical Data on Recent Advances with HIV VLP Vaccine Presented at AIDS Vaccine 07 Conference
6. Avicena Scientific Collaborator Advances Program for Using Energy Enhancing Molecules to Treat Neuromuscular Diseases
7. Groundbreaking Study Proves Personalized Diet Based on Genetics Leads to Significant Advances in Long Term Weight Management and Blood Glucose Levels
8. Thermo Fisher Scientific Advances Gene-Silencing Technology for Life Sciences Research
9. Stem Cell Breakthrough Advances Science Without Ethical Landmines, Says Cardinal
10. Financial Results for Full Year 2007: NicOx Significantly Advances Clinical Programs
11. MedImmune Advances Clinical Development of Antibody Targeting Interleukin-9 in Patients with Asthma

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/9/2009)...h., Nov. 9 Cardiac Sci...er in automated external defibrillator ( AED ) a...nounced revenue of $38.9 million for the third qua...evious guidance. The Company also recorded a charg... and a non-cash charge of $44.0 million to increas...
(Date:11/9/2009)...l., Nov. 9 Landauer, In... and environmental radiation monitoring services, ... in accordance with its long-term strategic priori...itions of Global Physics Solutions, Inc. (GPS) and..., President and CEO of Landauer. "These acquisitio...
(Date:11/9/2009)...v. 9 Keryx Biopharmaceut...company focused on the acquisition, development an...eutical products for the treatment of life-threate...(the "Company"), today announced its results for t...t September 30, 2009, the Company had cash, cash e...
Breaking Medicine Technology:Cardiac Science Announces Third Quarter Results 2Cardiac Science Announces Third Quarter Results 3Cardiac Science Announces Third Quarter Results 4Cardiac Science Announces Third Quarter Results 5Cardiac Science Announces Third Quarter Results 6Cardiac Science Announces Third Quarter Results 7Cardiac Science Announces Third Quarter Results 8Cardiac Science Announces Third Quarter Results 9Cardiac Science Announces Third Quarter Results 10Cardiac Science Announces Third Quarter Results 11Cardiac Science Announces Third Quarter Results 12Cardiac Science Announces Third Quarter Results 13Cardiac Science Announces Third Quarter Results 14Cardiac Science Announces Third Quarter Results 15Cardiac Science Announces Third Quarter Results 16Cardiac Science Announces Third Quarter Results 17Cardiac Science Announces Third Quarter Results 18Cardiac Science Announces Third Quarter Results 19Cardiac Science Announces Third Quarter Results 20Landauer Acquires Global Physics Solutions, Inc. as Platform to Expand Into Medical Physics Services Market 2Landauer Acquires Global Physics Solutions, Inc. as Platform to Expand Into Medical Physics Services Market 3Landauer Acquires Global Physics Solutions, Inc. as Platform to Expand Into Medical Physics Services Market 4Landauer Acquires Global Physics Solutions, Inc. as Platform to Expand Into Medical Physics Services Market 5Keryx Biopharmaceuticals, Inc. Announces Third Quarter 2009 Financial Results 2Keryx Biopharmaceuticals, Inc. Announces Third Quarter 2009 Financial Results 3Keryx Biopharmaceuticals, Inc. Announces Third Quarter 2009 Financial Results 4Keryx Biopharmaceuticals, Inc. Announces Third Quarter 2009 Financial Results 5Keryx Biopharmaceuticals, Inc. Announces Third Quarter 2009 Financial Results 6Proteolix Inc to be Acquired By Onyx Pharmaceuticals 59278 1Proteolix Inc to be Acquired By Onyx Pharmaceuticals 59278 2Proteolix Inc to be Acquired By Onyx Pharmaceuticals 59278 3Proteolix Inc to be Acquired By Onyx Pharmaceuticals 59278 4Raptor Pharmaceutical Reports Positive Interim Phase 2a Clinical Data in Non Alcoholic Steatohepatitis 28NASH 29 14428 1Raptor Pharmaceutical Reports Positive Interim Phase 2a Clinical Data in Non Alcoholic Steatohepatitis 28NASH 29 14428 2Raptor Pharmaceutical Reports Positive Interim Phase 2a Clinical Data in Non Alcoholic Steatohepatitis 28NASH 29 14428 3Raptor Pharmaceutical Reports Positive Interim Phase 2a Clinical Data in Non Alcoholic Steatohepatitis 28NASH 29 14428 4Raptor Pharmaceutical Reports Positive Interim Phase 2a Clinical Data in Non Alcoholic Steatohepatitis 28NASH 29 14428 5Raptor Pharmaceutical Reports Positive Interim Phase 2a Clinical Data in Non Alcoholic Steatohepatitis 28NASH 29 14428 6Irvine Scientific and Selexis to Announce Results of Successful Collaboration 14427 1Irvine Scientific and Selexis to Announce Results of Successful Collaboration 14427 2
...w Aggrastat Study in American Heart Journal , ,WI...TSX:MPH;,Amex:MCU), a cardiovascular focused, biop...o-year, follow-up results from the,STRATEGY (Singl...Stent Versus Abciximab and Bare Metal Stent In Acu...the July edition of the Journal,of the American Co...
...n., July 11, 2007 /PRNewswire/ -- Phase 3 results,...l dabigatran,etexilate once daily, administered fo...parin, also administered for an average of 33,days...ll-cause,mortality after total hip replacement sur...sociated with dabigatran etexilate was,similar to ...
Other Medicine Technology:Positive Aggrastat Results Featured in the Journal of the American,College of Cardiology 2Positive Aggrastat Results Featured in the Journal of the American,College of Cardiology 3Positive Aggrastat Results Featured in the Journal of the American,College of Cardiology 4Positive Aggrastat Results Featured in the Journal of the American,College of Cardiology 5Phase 3 Results for Dabigatran Etexilate, an Investigational Oral,Anticoagulant, Presented Today at the XXIst Congress of the,International Society on Thrombosis and Haemostasis 2Phase 3 Results for Dabigatran Etexilate, an Investigational Oral,Anticoagulant, Presented Today at the XXIst Congress of the,International Society on Thrombosis and Haemostasis 3Phase 3 Results for Dabigatran Etexilate, an Investigational Oral,Anticoagulant, Presented Today at the XXIst Congress of the,International Society on Thrombosis and Haemostasis 4Phase 3 Results for Dabigatran Etexilate, an Investigational Oral,Anticoagulant, Presented Today at the XXIst Congress of the,International Society on Thrombosis and Haemostasis 5
(Date:11/10/2009)...e to achieve exceptionally smooth surface finishin...such as ceramics, carbide and hardened tool steel ...-Hone® honing tool from Brush Research Techn...EB) November 10, 2009 -- Using exclusive, self-sha...lexible filaments, the Diamond Flex-Hone is a pate...
(Date:11/9/2009)... sizes looking to fast-track preparedness and resp...urce at their disposal. , ...source (HR) professionals looking to fast-track pr...mic have a new resource at their disposal. The Uni... Disease Research and Policy (CIDRAP), in collabor...
(Date:11/9/2009)...re-Asia-FirstCall/ -- Mindray Medical,Internationa...acturer and,marketer of medical devices worldwide,...results for the third quarter and nine months ende...tions as of September 30, 2009, -- Third quarte...se of, 3.1% over the third quarter of 2008. ...
(Date:11/9/2009)... promise to not expand abortion ,, Senate mus...rned for poor, elderly ,, WASHINGTON, Nov. 9 /...of Chicago, president of the United States Confere...ision of the U.S. House of Representatives to bloc... elective abortions. ,, In a statement issued ...
(Date:11/9/2009)...Variance Across the World is Critical in Understan... (Vocus) November 9, 2009 -- Understanding patie...ble when analyzing and interpreting scientific res...ned the genomes of 4,000 people throughout Europe ...an and Michael F. Seldin of the University of Cali...
Breaking Medicine News(10 mins):Health News:Diamond Honing Tool Technology: The New Standard in Surface Finishing of Hard Materials 2Health News:New H1N1 Flu Guide Offers Practical Tools and Tips for HR Professionals 2Health News:New H1N1 Flu Guide Offers Practical Tools and Tips for HR Professionals 3Health News:Mindray Announces Third Quarter 2009 Financial Results 2Health News:Mindray Announces Third Quarter 2009 Financial Results 3Health News:Mindray Announces Third Quarter 2009 Financial Results 4Health News:Mindray Announces Third Quarter 2009 Financial Results 5Health News:Mindray Announces Third Quarter 2009 Financial Results 6Health News:Mindray Announces Third Quarter 2009 Financial Results 7Health News:Mindray Announces Third Quarter 2009 Financial Results 8Health News:Mindray Announces Third Quarter 2009 Financial Results 9Health News:Mindray Announces Third Quarter 2009 Financial Results 10Health News:Mindray Announces Third Quarter 2009 Financial Results 11Health News:Mindray Announces Third Quarter 2009 Financial Results 12Health News:Mindray Announces Third Quarter 2009 Financial Results 13Health News:Mindray Announces Third Quarter 2009 Financial Results 14Health News:Mindray Announces Third Quarter 2009 Financial Results 15Health News:Mindray Announces Third Quarter 2009 Financial Results 16Health News:Mindray Announces Third Quarter 2009 Financial Results 17Health News:Mindray Announces Third Quarter 2009 Financial Results 18Health News:Cardinal George Lauds House Action to Ban Federal Funds for Abortion; Promises Vigilance as Senate Pursues Health Care Reform, Wary About Affect on Poor, Elderly 2Health News:Cardinal George Lauds House Action to Ban Federal Funds for Abortion; Promises Vigilance as Senate Pursues Health Care Reform, Wary About Affect on Poor, Elderly 3Health News:News from the November/December Issue of Molecular Medicine 2
..., OH January 14, 2009 Obesity continues to incre...mong African-American and Mexican-American women. ... 3.3 million white women, 1.4 million African-Amer...creased risk for midlife obesity among Mexican-Ame...
...cing the First and Only Non-Drowsy Allergy Medicin....J., Jan. 14 Schering-Plough Corporation (NYSE: ...RITIN(R) Liqui-Gels(R), the first and only non-dro...lief for the worst allergy symptoms without causin...
...E, N.J., Jan. 14 Nephros, Inc. (Amex: NEP ), is...tigious 2009 Frost & Sullivan Medical Device P...apid growth, progressive technology, and strategic...tion technology has resulted in rapid revenue grow...
...RSE CITY, Mich., Jan. 14 Versus Technology,Inc. (... Management(TM) at,Anne Arundel Medical Center (AA...of efficiency and equipment monitoring at the 300+...al center, improving staff,efficiency and allowing...
...eople sickened in outbreak rises to 425 in 43 stat...hDay News) -- As the number of people sickened by ...in 43 states, state health officials said Tuesday ...ometowns haven,t been released, died from salmonel...
... Promotes the Pearl of Wisdom(TM) as Worldwide Sym..., Jan. 14 Marking Cervical Cancer Awareness Month... health advocacy groups, policymakers, healthcare ...Pearl of Wisdom Campaign to Prevent Cervical Cance...
Other Medicine News:Health News:Economic status affects obesity rates in Mexican-American and white women 2Health News:New Non-Drowsy CLARITIN(R) Liqui-Gels(R) Now Available 2Health News:New Non-Drowsy CLARITIN(R) Liqui-Gels(R) Now Available 3Health News:Nephros, Inc. Receives the 2009 Frost & Sullivan Medical Device Patient Care Company of the Year Award 2Health News:Nephros, Inc. Receives the 2009 Frost & Sullivan Medical Device Patient Care Company of the Year Award 3Health News:Nephros, Inc. Receives the 2009 Frost & Sullivan Medical Device Patient Care Company of the Year Award 4Health News:Nephros, Inc. Receives the 2009 Frost & Sullivan Medical Device Patient Care Company of the Year Award 5Health News:Nephros, Inc. Receives the 2009 Frost & Sullivan Medical Device Patient Care Company of the Year Award 6Health News:Versus Technology, Inc. Announces Successful Implementation of Automatic Hospital Tracking System at Anne Arundel Medical Center 2Health News:Versus Technology, Inc. Announces Successful Implementation of Automatic Hospital Tracking System at Anne Arundel Medical Center 3Health News:Versus Technology, Inc. Announces Successful Implementation of Automatic Hospital Tracking System at Anne Arundel Medical Center 4Health News:Salmonella Linked to Deaths in Virginia, Minnesota 2Health News:Salmonella Linked to Deaths in Virginia, Minnesota 3Health News:U.S. and European Advocacy Groups Launch United, Global Campaign to Prevent Cervical Cancer 2Health News:U.S. and European Advocacy Groups Launch United, Global Campaign to Prevent Cervical Cancer 3Health News:U.S. and European Advocacy Groups Launch United, Global Campaign to Prevent Cervical Cancer 4
... doors, 8 shelves. Over-sized compressor. Tripl...scent interior lighting. Self-Contained System No... Full One Year Warranty on Parts & Labor and an Ad...ilable as a chromatography unit which includes two...
... door 4 shelves. Over-sized compressor. Triple ...ent interior lighting. Self-Contained System No p...ull One Year Warranty on Parts & Labor and an Addi...able as a chromatography unit which includes two a...
Flammable Chemical Storage Cabinets, Justrite Model J25452
Flammable Chemical Storage Cabinets
Medicine Products: